본문으로 건너뛰기
ProhibitedBinding ruleSAOriginal is English공식 출처 가져오기 확인됨

Imazamox (ISO); (RS)-2-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)-5-methoxymethylnicotinic acid

Listed by the Saudi Food and Drug Authority as prohibited in cosmetic products.

규제 판단 및 전체 조건

상태
Prohibited
법적 역할
Binding rule
규제 요약
Listed by the Saudi Food and Drug Authority as prohibited in cosmetic products.
조건 및 제한 사항
A prohibition entry may contain no separate condition text because the regulatory outcome is the prohibition itself. 인용된 출처를 열고 아래의 시장 전체 요건을 적용하세요.

물질 정체

공식 출처상의 명칭
Imazamox (ISO); (RS)-2-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)-5-methoxymethylnicotinic acid
CAS
114311-32-9
EC
Not supplied in this source row
정체 매핑
standalone:official_sfda_record

이 정체의 시장 간 요약

현재 이 사이트에 있는 정확히 연결된 기록입니다. 시장이 없는 것은 가져온 정확한 일치 항목이 없다는 뜻이며, 해당 물질의 사용이 허용된다는 뜻이 아닙니다.

시장 데이터세트 5개
CAS 114311-32-9의 PubChem 2D 화학 구조
CAS 114311-32-9PubChem CID 86137

CAS 114311-32-9의 검증된 화학 정보

Imazamox

2-(4-isopropyl-4-methyl-5-oxo-4,5-dihydro-1H-imidazol-2-yl)-5-(methoxymethyl)nicotinic acid is a pyridinemonocarboxylic acid that is nicotinic acid which is substituted substituted at position 5 by a methoxymethyl group and at position 2 by a 4,5-dihydro-1H-imidazol-2-yl group, that in turn is substituted by isopropyl, methyl, and oxo groups at positions 4, 4, and 5, respectively. It is an imidazolone, an ether, a pyridinemonocarboxylic acid and a member of imidazolines. — ChEBI

IUPAC 명칭
5-(methoxymethyl)-2-(4-methyl-5-oxo-4-propan-2-yl-1H-imidazol-2-yl)pyridine-3-carboxylic acid
분자식
C15H19N3O4
분자량
305.33 g/mol
정확한 질량
305.13755610 Da
단일 동위원소 질량
305.13755610 Da
XLogP3
0.9
위상 극성 표면적
101.0 Ų
분자 복잡도
491.0
형식 전하
0
수소 결합 공여체
2
수소 결합 수용체
6
회전 가능 결합
5
중원자
22
공유결합 단위
1

PubChem에 보고된 명칭 및 동의어

PulsarRaptorRaptor (herbicide)(+-)-ImazamoxUG6793ON5FAC 299263CL 299263SWEEPER 70DG
보고된 명칭 16개 더 보기
AC-299263CL-2992632-(4,5-Dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1H-imidazol-2-yl)-5-(methoxymethyl)-3-pyridinecarboxylic acid2-[4,5-Dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1H-imidazol-2-yl]-5-(methoxymethyl)-3-pyridinecarboxylic acid3-Pyridinecarboxylic acid, 2-[4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1H-imidazol-2-yl]-5-(methoxymethyl)-5-Methoxymethyl-2-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)nicotinic acid3-Pyridinecarboxylic acid, 2-(4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1H-imidazol-2-yl)-5-(methoxymethyl)-5-(methoxymethyl)-2-[4-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-imidazol-2-yl]pyridine-3-carboxylic acid5-(methoxymethyl)-2-(4-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-imidazol-2-yl)pyridine-3-carboxylic acidRefChem:790602CHEBI:81857Imazamox [ISO]CL29926;(+/-)-ImazamoxHSDB 7013UNII-UG6793ON5FEINECS Annex I Index 613-208-00-7
외부 데이터베이스 식별자
고급 구조 통계
정의된 원자 입체중심
0
정의되지 않은 원자 입체중심
1
정의된 결합 입체중심
0
정의되지 않은 결합 입체중심
0
3D 파마코포어 특성
10
3D 고리
2
3D 소수성 부위
1
3D 수용체 특성
5
3D 공여체 특성
1
3D 음이온 중심
1
3D 양이온 중심
0
3D 형태이성질체
10
유효 3D 회전자
5.4
기계 판독 가능한 구조 식별자
SMILES
CC(C)C1(C(=O)NC(=N1)C2=C(C=C(C=N2)COC)C(=O)O)C
InChI
InChI=1S/C15H19N3O4/c1-8(2)15(3)14(21)17-12(18-15)11-10(13(19)20)5-9(6-16-11)7-22-4/h5-6,8H,7H2,1-4H3,(H,19,20)(H,17,18,21)
InChIKey
NUPJIGQFXCQJBK-UHFFFAOYSA-N

추가 과학 데이터베이스의 근거

NIH PubChem PUG-View
식별자 정확히 일치86137

Attributed physical-property, hazard, environmental and use annotations.

  • Toxicity Summary: IDENTIFICATION AND USE: Imazamox is off-white powdered solid. It is a herbicide applied post-emergence in soybean. HUMAN STUDIES: In an in vitro study, human embryonic stem cells were treated with imazamox at a concentration of 0, 1, 10 or 100 umol/L, incubation did not induce cytotoxicity. ANIMAL STUDIES: In the acute toxicity studies, the substance has low acute toxicity when administered orally, dermally or by inhalation to rats. It is not a significant skin or eye irritant or a skin sensitizer. Imazamox showed no short-term and long-term toxicity after oral exposure to rats, mice and dogs up to the limit top dose level tested in each study. Based on available genotoxicity studies imazamox is unlikely to be genotoxic. The substance showed no carcinogenic potential in both species. In the multigeneration toxicity study, fertility and overall reproductive performance was not impaired. In developmental toxicity studies maternal toxicity in rats and in rabbits was observed. No developmental toxicity was observed in rats whereas agenesis of the intermediate lobe of lung and cervical hemivertebra was observed in rabbits. ECOTOXICITY STUDIES: Imazamox is practically nontoxic to avian s 출처: Hazardous Substances Data Bank (HSDB)
  • Environmental Bioconcentration: Imazamox concentrations in whole and edible bluegill fish tissue were below the quantification limit, and the BCF for inedible tissue was less than 1X the concentration tested(1). An estimated BCF of 3.2 was calculated in fish for imazamox(SRC), using a log Kow of 0.73(2) and a regression-derived equation(3). According to a classification scheme(4), this BCF data suggests the potential for bioconcentration in aquatic organisms is low(SRC). 출처: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: TERRESTRIAL FATE: Based on a classification scheme(1), Koc values ranging from 5 to 143(2) indicate that imazamox is expected to have very high mobility in soil(SRC). The pKa values of imazamox have been reported as 2.3, 3.3 and 10.8(3), indicating that this compound will exist entirely in anion form in the environment and anions generally do not adsorb as strongly to soils containing organic carbon and clay as their neutral counterparts(4). Volatilization of imazamox is not expected to be an important fate process(SRC) because this chemical expected to exist as an anion in the environment and anions do not volatilize. Imazamox is primarily degraded by microbes in soil under aerobic conditions(2,3); essentially no degradation occurs under anaerobic conditions(2). Imazamox is considered moderately persistent with half-lives ranging between 15 to 142 days(2,3); its limited persistence will restrict leaching of imazamox into groundwater(2). 출처: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: TERRESTRIAL FATE: In a field study with 5 soils, terrestrial dissipation half-lives ranged between 15 and 130 days(1). Leaching was found to be very limited in field studies(2). 출처: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: AQUATIC FATE: Based on a classification scheme(1), Koc values ranging from 5 to 143(2) indicate that imazamox is not expected to adsorb to suspended solids and sediment(SRC). The pKa values of imazamox have been reported as 2.3, 3.3 and 10.8(3) indicating imazamox will exist entirely in the anion form at pH values of 5 to 9 and, therefore, volatilization from water surfaces is not expected to be an important fate process(SRC). According to a classification scheme(4), an estimated BCF of 3.2(SRC), from its log Kow of 0.73(5) and a regression-derived equation(6), suggests the potential for bioconcentration in aquatic organisms is low(SRC). Photodegradation can be rapid with a half-life of 6.8 hours observed in laboratory studies(2,3); this rate is only applicable at the surface of the water with rates decreasing with water depth. Imazamox is stable to hydrolysis at pH 5, 7 and 9(2). Imazamox is considered moderately persistent in soil with half-lives ranging between 15 to 142 days(2,3). 출처: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: ATMOSPHERIC FATE: According to a model of gas/particle partitioning of semivolatile organic compounds in the atmosphere(1), imazamox, which has an estimated vapor pressure of 1.26X10-11 mm Hg at 25 °C determined from a fragment constant method(2), is expected to exist solely in the particulate phase in the ambient atmosphere. Particulate-phase imazamox may be removed from the air by wet and dry deposition(SRC). Imazamox photolytically decays with reported half-lives of 6.8 hours (or 0.3 days)(5,6) and 78 minutes (or 3 days)(7) for primary degradation in aqueous media. Direct aqueous photolysis results in several stable degradates(7). Photolysis in soil is a slower process with a half-life of 65 days(6). The rate of photodegradation decreases in the presence of Cu(II) and Ca(II) salts which form stable complexes with imazamox(7). 출처: Hazardous Substances Data Bank (HSDB)

매핑 기준: Existing checksum-valid CAS to unique PubChem CID match. 가져온 시각: 2026-08-31. 출처 기록 열기

과학적 분류와 유해성 주석은 맥락을 제공할 뿐이며, 위에 표시된 시장별 규제 판단을 대체하지 않습니다.

추가 출처 적용 범위 및 일치 상태
출처결과확인됨
NIH PubChem PUG-View정확히 일치2026-08-31

기록된 불일치는 출처를 확인했다는 유용한 근거이며, 해당 물질이 다른 곳에 존재하지 않는다는 주장이 아닙니다.

체크섬이 유효한 CAS 일치를 통해 2026-09-02에 NIH PubChem에서 가져왔습니다. 화학적 특성은 이 페이지의 규제 판단을 대체하지 않습니다.

공식 출처 및 출처 정보

등록된 출처
Saudi SFDA prohibited and restricted ingredient lists
출처 참조
SFDA prohibited list, page 169, row 5
출처 기록 ID
prohibited-168-5
출처 버전
live-snapshot-2026-08-30
출처 언어
English
번역 상태
Original is English
스냅샷 확인
2026-08-30 05:18 UTC
검증 방법
complete SFDA paginated HTML snapshot; strict page/row counts
SHA-256
ceb6cc636e6b1f4b3013f88ce0297217b49d6194342c6ece5c03b1e04256d71a

등록된 데이터세트 주석

데이터세트 적용 범위
Prohibited and restricted substances with CAS, EC and conditions
권위 관련 주석
Official SFDA dated lists; version and hash each release

이 기록이 시장 데이터세트에서 차지하는 위치

2090
현재 Saudi Arabia 기록
1726
Prohibited(으)로 표시된 기록
2090
이 출처 버전의 기록
1991
CAS 정체가 있는 시장 기록

상태 분포

현재 기록 2090건 중 0건에 조건 텍스트가 있습니다. 조건 필드가 비어 있는 경우 위의 기록 유형에 따라 해석되며, 제한 없는 사용에 대한 주장으로 전환되지 않습니다.

Saudi Arabia 시장 맥락

Complete official list index

적용 범위 버전: SFDA live prohibited/restricted lists, snapshot 30 August 2026

Every page and entry in the public SFDA prohibited and restricted ingredient indexes; restricted detail pages remain the source for conditions.

확인 체크리스트

  1. Search names and CAS across both SFDA lists.
  2. Open the cited restricted-entry detail and apply every condition.
  3. Check current SFDA/GSO technical regulations and updates.
  4. Complete eCosma notification, label and responsible-party requirements.

공식 시장 출처

확인 절차 및 기록 완전성

이 결과를 규제 준수 판단에 사용하기 전에

  1. “Imazamox (ISO); (RS)-2-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)-5-methoxymethylnicotinic acid”와(과) 모든 CAS/EC 식별자가 공급업체 규격서의 물질을 가리키는지 확인하세요.
  2. Search names and CAS across both SFDA lists.
  3. Open the cited restricted-entry detail and apply every condition.
  4. Check current SFDA/GSO technical regulations and updates.
  5. Complete eCosma notification, label and responsible-party requirements.
  6. 출처 버전을 기록하고, 제조, 신고 또는 시장 출시 전에 규제 기관을 다시 확인하세요.

이 기록에서 제공되는 필드

  • 공식 물질 명칭제공됨
  • CAS제공됨
  • EC제공되지 않음
  • 별도의 조건 텍스트출처 행에 없음
  • 시행일제공되지 않음
  • 스냅샷 해시 및 방법제공됨

이 페이지가 답하는 질문

This official record identifies the substance as prohibited for cosmetic use in the stated market scope. Do not rely on a formulation containing this identity until the cited source, effective date and exact substance match have been verified.

A prohibition entry may contain no separate condition text because the regulatory outcome is the prohibition itself. No list match is not permission; Gulf/SFDA product, claim, notification and technical requirements still apply.

이 기록은 SFDA prohibited list, page 169, row 5, 출처 버전 live-snapshot-2026-08-30을(를) 인용합니다. 공식 출처를 여세요.

아니요. CAS는 정체를 확인하는 데 도움이 되지만, 관할권마다 같은 물질을 다르게 분류할 수 있으며 제품 범위, 한도, 경고 문구 및 경과 기간 날짜를 다르게 적용할 수 있습니다.

안정적인 인용

Imazamox (ISO); (RS)-2-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)-5-methoxymethylnicotinic acid. SFDA prohibited list, page 169, row 5. Saudi Arabia. Source version live-snapshot-2026-08-30. CosIng Checker regulatory record: https://cosingchecker.com/ko/regulations/sa/records/11264/

법적 권위로서 규제 기관을 인용하세요. 이 페이지는 구조화된 근거 색인이자 확인 보조 도구이며, 공식 본문이나 전문적인 법률 평가를 대체하지 않습니다.

Saudi Arabia의 해석 및 한계

This official record identifies the substance as prohibited for cosmetic use in the stated market scope.

Do not rely on a formulation containing this identity until the cited source, effective date and exact substance match have been verified.

법적 역할 해석 방법

The cited row forms part of a binding rule or legally incorporated list for this market.

이 페이지의 근거

  • 기록된 결과: Prohibited
  • 법적 역할: Binding rule
  • 출처 버전: live-snapshot-2026-08-30

증명하지 않는 것

No list match is not permission; Gulf/SFDA product, claim, notification and technical requirements still apply.

추가 공신력 있는 물질 조사

이 출처들 중 어느 것도 위의 시장 판단을 번복하지 않습니다.

Cosmetic Ingredient Review safety assessments

Expert Panel conclusions, assessed ingredient groups, use conditions, dates and report documents

Independent expert review considered by FDA; not a government approval or binding market rule

출처에서 이 정체 조사

FDA Global Substance Registration System

UNII identifiers, preferred names, substance types, codes and public substance relationships

Identity registry only; UNII availability does not imply FDA review or approval

출처에서 이 정체 조사

ILO/WHO International Chemical Safety Cards

Hazards, symptoms, first aid, storage, incompatibilities and physical properties for covered chemicals

International occupational chemical-safety reference; not cosmetic-use approval

출처에서 이 정체 조사

Japan NITE-CHRIP

Chemical identity, Japanese and foreign legal lists, GHS hazards and exposure-related information

Chemical-management evidence; cosmetic status remains governed by the applicable MHLW standard and market rules

출처에서 이 정체 조사

NIOSH Pocket Guide to Chemical Hazards

REL, PEL, IDLH, properties, exposure routes, symptoms, target organs, first aid and measurement methods for covered workplace chemicals

US occupational-health guidance and limits; not a cosmetic ingredient decision

출처에서 이 정체 조사

OECD eChemPortal

Gateway to authority-owned physical-property, fate, ecotoxicity, toxicity, exposure and GHS records

Discovery gateway; each linked authority remains responsible for its data

출처에서 이 정체 조사

US EPA CompTox CTX APIs

가져오기에 API 키 필요

DTXSID identity, experimental and predicted properties, toxicity, bioactivity, exposure and environmental data

Scientific and computational evidence; predictions must remain labelled and do not determine cosmetic legality

출처에서 이 정체 조사